The diabetes drug you've heard of for 60 years just revealed a secret — it's been working on your brain all along.

Some patients with type 2 diabetes will be able to switch from daily insulin injections to this first-of-its-kind once-weekly alternative.

Kresladi becomes the first FDA-approved gene therapy for children with severe LAD-I due to biallelic variants in ITGB2, and ...

Metformin has been prescribed to people with type 2 diabetes to manage blood sugar for more than 60 years, but scientists ...

The approval offers the only once‑weekly basal insulin option, providing a new treatment solution that fits different patient ...

Metformin is particularly effective for people with diabetes or prediabetes who have obesity and have difficulty managing their blood sugar through lifestyle changes alone. Metformin is a widely used ...

Adults with type 1 diabetes had an increase in total daily insulin dose and bolus insulin dose shortly after stopping ...

If you or someone you love has been diagnosed with type 1 diabetes (T1D), a genuine miracle is on the horizon: a type 1 ...

A one-size-fits-all approach to prediabetes treatment may miss the opportunity to implement an early, more intensive, ...

No increased risk for preterm birth seen in association with periconceptional exposure to GLP-1 receptor agonists for weight ...